I personally believe a UK approval is imminent as do most but I also believe a UK approval isn't instant glory. It's very significant milestone but it's not enough to get us to $10-$15 sp. I personally think Linda powers has no appetite to "ride the wave" of NWBO and is looking for buyout. Patents are the bluff card of NWBO to BP... I think NWBO is relying on their other clinical trials progressing to phase 3 to be a catalyst as well. But it's not in Linda powers interests at her age to not seek buyout. Of course she will pretend to be against one but once sp gets to $5-$10 she will be looking to sell and gain leverage for reasonable price of IP. Personally, I hope she goes this route. People need to stop falling in love with Big tech 100X stories and hope for a decent payout.
Market Data 
Markets 
AI
